Medicis Pharmaceutical Corp. (MRX) Tops Q4 EPS by 14c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $64.24 -2.44%
Revenue Growth %: +19.2%
Financial Fact:
Income from continuing operations before income tax expense: 1.82M
Today's EPS Names:
OVLY, UTMD, AMBZ, More
Revenue Growth %: +19.2%
Financial Fact:
Income from continuing operations before income tax expense: 1.82M
Today's EPS Names:
OVLY, UTMD, AMBZ, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q4 EPS of $1.13, $0.14 better than the analyst estimate of $0.99. Revenue for the quarter came in at $572.1 million versus the consensus estimate of $508.62 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Misses Q2 EPS by 16c; offers guidance
- Utah Medical Products (UTMD) Tops Q2 EPS by 84c
- (ECBK) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
